Stay updated on APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial

Sign up to get notified when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T16:10:48.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-11T16:30:24.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.7.0, indicating a recent update to the study record; the older revision v3.6.6 has been removed from the history list.
    Difference
    0.1%
    Check dated 2026-09-20T20:07:56.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    There are no additions or deletions listed for the study record history, so the page content remains in its current state.
    Difference
    0.1%
    Check dated 2026-09-06T18:43:24.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.6.6. The previous v3.6.5 entry has been removed from the list.
    Difference
    0.1%
    Check dated 2026-08-30T16:17:19.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.6.5, was added to the history and the previous tag, Revision: v3.6.4, was removed.
    Difference
    0.1%
    Check dated 2026-08-09T00:29:16.000Z thumbnail image

Stay in the know with updates to APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.